Bacterial vaginosis

Annual Review of Medicine

Volumn 51, Issue , 2000, Pages 349-356

  Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complications; Diagnosis; Epidemiology; Pathogenesis; Treatment

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CLINDAMYCIN; METRONIDAZOLE;

DIAGNOSTIC TEST; GARDNERELLA VAGINALIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOM; VAGINA FLORA; VAGINITIS;

FEMALE; HUMANS; VAGINOSIS, BACTERIAL;

EID: 0034094263     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.51.1.349     Document Type: Review

References (37)

1. 1. Hillier SL, Holmes KK. 1999. Bacterial vaginosis. In Sexually Transmitted Diseases, ed. KK Holmes, PA Mardh, PF Sparling, et al, pp. 563-87. New York: McGraw-Hill
2. 2. Eschenbach DA, Davick PR, Williams BL. 1989. Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis. J. Clin. Microbiol. 27:251-56
3. 3. Hawes SE, Hillier SL, Benedetti F, et al. 1996. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J. Infect. Dis. 174:1058-63
4. 4. Thorsen P, Jensen IP, Jeune B, et al. 1998. Few microorganisms associated with bacterial vaginosis may constitute the pathologic care: a population-based microbiologic study among 3596 pregnant women. Am. J. Obstet. Gynecol. 178:580-87
5. 5. Hill GB. 1993. Microbiology of bacterial vaginosis. Am. J. Obstet. Gynecol. 169: 450-54
6. 6. Gardner H, Dukes CD. 1955. Hemophilus vaginalis vaginitis a newly defined specific infection previously classified "non-specific" vaginitis. Am. J. Obstet. Gynecol. 69:962-76
7. 7. Amsel R, Totten PA, Speigel CA, et al. 1983. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am. J. Med. 74:14-22
8. 8. Eschenbach DA, Hillier SL, Critchlow C, et al. 1988. Diagnosis and clinical manifestations of bacterial vaginosis. Am. J. Obstet. Gynecol. 158:819-28
9. 9. Nugent RP, Krohn MA, Hillier SL. 1991. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J. Clin. Microbiol. 29:297-301
10. 10. Sheiness D, Dix K, Watanabe S, Hillier SL. 1992. High levels of Gardnerella vaginalis detected with an oligonucleotide probe combined with elevated pH as a diagnostic indicator of bacterial vaginosis. J. Clin. Microbiol. 30:642-45
11. 11. Deleted in proof
12. 12. Oleen-Burkey MA, Hillier SL. 1995. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect. Dis. Obstet. Gynecol. 3: 149-57
13. 13. Hillier SL, Nugent RP, Eschenbach DA, et al. 1995. Association between bacterial vaginosis and preterm delivery of a low birth weight infant. N. Engl. J. Med. 333:1737-42
14. 14. Hillier SL, Martius J, Kroh M, et al. 1988. A case control study of chorioamnionic infection and histologic chorioamnionitis in prematurity. N. Engl. J. Med. 319:971-78
15. 15. Eschenbach DA. 1989. Bacterial vaginosis: emphasis on upper genital tract complications. Obstet. Gynecol. Clin. N. Am. 16:593-610
16. 16. Kurki T, Sivonen A, Renkonen O, et al. 1992. Bacterial vaginosis in early pregnancy and pregnancy outcomes. Obstet. Gynecol. 80:173-77
17. 17. Hay PE, Lamont RF, Taylor-Robinson D, et al. 1994. Abnormal bacterial colonization of the genital tract and subsequent preterm delivery and late miscarriage. Br. Med. J. 308:295-98
18. 18. McGregor JA, French JJ, Parker R, et al. 1995. Prevention of premature birth by screening and treatment of common genital tract infections: results of a prospective controlled evaluation. Am. J. Obstet. Gynecol. 173:157-67
19. 19. Morales WJ, Schorr S, Albritton J. 1994. Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am. J. Obstet. Gynecol. 71:345-49
20. 20. Hauth JC, Goldenberg RL, Andrews WW, et al. 1995. Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N. Engl. J. Med. 333:1732-36
21. 21. MacDermott RIJ. 1995. Bacterial vaginosis. Br. J. Obstet. Gynaecol. 102:92-94
22. 22. Soper DE, Brockwell N, Dalton HJ. 1994. Observations concerning the microbial etiology of acute salpingitis. Am. J. Obstet. Gynecol. 170:1008-17
23. 23. Korn AP, Bolan G, Padian N, et al. 1995. Plasma cell endometritis in women with symptomatic bacterial vaginosis. Obstet. Gynecol. 85:387-90
24. 24. Moi H. 1990. Prevalence of bacterial vaginosis and its association with genital infections, inflammation, and contraceptive methods in women attending sexually transmitted disease and primary health clinics. Int. J. STD AIDS 1:86-94
25. 25. Paavonen J, Critchlow CW, DeRouen T, et al. 1986. Etiology of cervical inflammation. Am. J. Obstet. Gynecol. 154: 556-64
26. 26. Schwebke JR, Schuken MB, Zajackowski M. 1995. Pilot study to evaluate the appropriate management of patients with coexistent bacterial vaginosis and cervicitis. Infect. Dis. Obstet. Gynecol. 3:119-22
27. 27. Eltabbakh GH, EItabbakh MS, Broekhuizen FF, Griner BR. 1995. Value of wet mount and cervical cultures at the time of cervical cytology in asymptomatic women. Obstet. Gynecol. 85:499-503
28. 28. Soper DE, Bump RC, Hurt WR. 1990. Bacterial vaginosis and trichomoniasis are risk factors for cuff cellulitis after abdominal hysterectomy. Am. J. Obstet. Gynecol. 163:1016-21
29. 29. Penney GC, Thompson M, Norman J, et al. 1998. A randomised comparison of strategies for reducing infective complications of induced abortion. Br. J. Obstet. Gynaecol. 105:599-604
30. 30. Platz-Christensen JJ, Sundstrom E, Larsson PG. 1994. Bacterial vaginosis and cervical intraepithelial neoplasia. Acta Obstet. Gynecol. Scand. 73:586-88
31. 31. Peters N, Van Leeuwen AM, Pieters WJLM, et al. 1995. Bacterial vaginosis is not important in the etiology of cervical neoplasia: a survey of women with dyskariotic smears. Sex. Trans. Dis. 22: 296-302
32. 32. Joesoef MR, Schmid GP. 1995. Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin. Infect. Dis. 20(Suppl.1):572-79
33. 33. Ferris DG, Litaker MS, Woodward L, et al. 1995. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel and clindamycin vaginal cream. J. Fam. Pract. 41:443-49
34. 34. Ahmed-Jushuf IH, Shahmanesh M, Arya OP. 1995. The treatment of bacterial vaginosis with a 3 day course of 2% clindamycin cream: results of a multicenter, double blind, placebo controlled trial. Genitourin. Med. 71:254-66
35. 35. Colli E, Landoni M, Parazzini F. 1997. Treatment of male partners and recurrence of bacterial vaginosis: a randomized trial. Genitourin. Med. 73:267-70
36. 36. Cohn RM, Duerr A, Priuthinithoda H, et al. 1995. Bacterial vaginosis and HIV seroprevalence among female commercial sex workers in Chang Mai, Thailand. AIDS 9:1093-97
37. 37. Sweankambo N, Gray NH, Wawer MJ, etal. 1997. HIV infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1350:546-50